Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

Explore innovative treatments for spinal cord injury in clinical trials, including Lineage's OPC1 and NervGen's NVG-291, ...

Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and leading to ...

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ...

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Through an alliance announced last July, Pfizer has partnered with venture firm Flagship Pioneering to develop 10 new drug ...

Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving ...